Roberto Vargas

Cleveland Clinic — United States

Medicine · Health Sciences

28h-index3.2kcitations159works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(49), Endometrial and Cervical Cancer Treatments(34), Gut microbiota and health(14), Intraperitoneal and Appendiceal Malignancies(14), Cervical Cancer and HPV Research(10)

Publications159 total

Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer
Journal of Gynecologic Oncology·2026Open Access
Interval versus primary cytoreductive surgery in BRCA-mutated advanced-stage ovarian/peritoneal/tubal carcinoma
International Journal of Gynecological Cancer·2025
Supplementary Data from Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
2025Open Access
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol
Gynecologic Oncology·2025Open Access
Evolutionary experimentation highlights novel collateral sensitivity to etoposide in platinum-resistant endometrial cancer
Gynecologic Oncology·2025
NSC59984 as a potent radiosensitizer and cytotoxic agent in TP53-mutated endometrial cancer
Gynecologic Oncology·2025
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancer
npj Precision Oncology·2025· 1 citedOpen Access
Prognostic factors and treatment outcomes in stage IV endometrial carcinoma: A 13-year single center experience.
Journal of Clinical Oncology·2025
Abstract 4322: NSC59984 is a radiosensitizer and cytotoxic agent in <i>in vitro</i> and <i>in vivo</i> models of <i>TP53mut</i> endometrial cancer
Cancer Research·2025
Abstract 1821: <i>In vivo</i> synergy is observed with AMG-232 and radiotherapy in endometrial cancer
Cancer Research·2025
Abstract 4691: Concurrent EGFR inhibition and radiotherapy potentiates radioresistance in <i>TP53</i>-mutated endometrial cancer
Cancer Research·2025
Assessment of readability of informed consent forms of gynecologic cancer clinical trials: A (Potential) barrier to enrollment?
Gynecologic Oncology Reports·2025Open Access
A working group report from the 2024 National Cancer Institute / Gynecologic Cancer Steering Committee endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy era
JNCI Journal of the National Cancer Institute·2025· 3 citedOpen Access
Assessment of readability of gynecologic cancer clinical trials literature at National Cancer Institute–designated Comprehensive Cancer Centers
International Journal of Gynecological Cancer·2025
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258
Gynecologic Oncology·2025· 13 citedOpen Access
Assessment of Readability of Informed Consent Forms of Gynecologic Cancer Clinical Trials: A (Potential) Barrier to Enrollment?
SSRN Electronic Journal·2025Open Access
Molecular Classification of Endometrial Cancers (EC) and Association with Relapse-Free Survival (RFS) and Overall Survival (OS) Outcomes: Ancillary Analysis of GOG-0258
SSRN Electronic Journal·2025Open Access
Uterine manipulation during minimally invasive surgery for early-stage endometrial cancer (MAN-U trial)
Gynecologic Oncology·2024
Overall survival among patients in GOG-0258 by molecular classification with a modified ProMisE algorithm: Ancillary analysis of GOG-0258
Gynecologic Oncology·2024· 3 cited
Financial toxicity associated with obtaining childcare while undergoing therapy for gynecologic malignancies
Gynecologic Oncology·2024
page 1 of 8Next →

Frequent Co-authors

Laura Chambers(11), Chad M. Michener(11), Peter W. Ramwell(9), Peter G. Rose(7), Meng Yao(7), Ofer Reizes(6), Robert Debernardo(6), Barbara Wróblewska(5), Lisa Barroilhet(4), Daniela Matei(4), David S. Miller(4), John O. Schorge(4), Michel Y. Farhat(4), Ramwell Pw(4), Molly Morton(4), Deborah K. Armstrong(3), Ronald D. Alvarez(3), Kian Behbakht(3), Andrew Berchuck(3), Eric Eisenhauer(3)